Cargando…
Usefulness and robustness of Immunoscore for personalized management of cancer patients
This review details the analytical performance characteristics of the consensus Immunoscore, measuring the immune response to cancer, improving the estimation of risk of recurrence, and predicting response to treatment for patients with colon cancer. The analytical validation of Immunoscore has been...
Autores principales: | Marliot, Florence, Pagès, Franck, Galon, Jérôme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644247/ https://www.ncbi.nlm.nih.gov/pubmed/33194318 http://dx.doi.org/10.1080/2162402X.2020.1832324 |
Ejemplares similares
-
The consensus immunoscore: toward a new classification of colorectal cancer
por: Lanzi, Anastasia, et al.
Publicado: (2020) -
The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions
por: Pagès, Franck, et al.
Publicado: (2020) -
Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer
por: Nassif, Elise F., et al.
Publicado: (2021) -
The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions
por: Lanzi, Anastasia, et al.
Publicado: (2020) -
Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer
por: El Sissy, Carine, et al.
Publicado: (2021)